Sheng-Wen Lin

Associate Scientist Ii @AbbVie

South San Francisco, CA, US

Led 7+ product discovery initiatives from ideation through delivery, aligning outcomes with therapeutic and business goals while managing trade-offs across stakeholders.• Built a scalable yeast display platform, streamlining candidate screening and accelerating identification of high-affinity antibodies.• Implemented innovative approaches (epitope steering, light chain shuffling, reverse engineering) that enhanced antibody specificity, affinity, and cross-reactivity to meet evolving product requirements.• Collaborated with cross-functional stakeholders to define requirements, evaluate trade-offs, and deliver optimized antibody solutions with improved specificity, affinity, and cross-reactivity.• Designed and implemented a regeneration and reuse process within the antibody screening workflow, reducing consumable costs in the screening step by 87.5% and improving process efficiency.